Imaging, Protein Production, and Chemical Biology Core
成像、蛋白质生产和化学生物学核心
基本信息
- 批准号:10613966
- 负责人:
- 金额:$ 51.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AlkynesAntibodiesAntibody FormationAzidesBindingBinding SitesBiologyBiomedical ResearchBiotinCellsChemicalsChemistryCholesterolCholesterol HomeostasisDiazomethaneDiseaseElectron MicroscopeElectron MicroscopyElectronsEnsureEnzyme-Linked Immunosorbent AssayEquipmentFab ImmunoglobulinsFluorescence MicroscopyFundingGoalsHealthHigh Density LipoproteinsHuman ResourcesImageInsectaInvestigationIsotopesLabelLightLipidsMass Spectrum AnalysisMicroscopyMovementNational Heart, Lung, and Blood InstitutePreparationProductionProductivityProteinsProteolysisProteomeProteomicsProtocols documentationReagentRecombinant AntibodyRecombinant ProteinsRegulationResearchResearch PersonnelSamplingScanning Electron MicroscopyServicesSignal TransductionStable Isotope LabelingSterolsStructureSystemTertiary Protein StructureTissuesTransmission Electron MicroscopyTriglyceride MetabolismVisualizationactivity-based protein profilingcellular imagingcostcrosslinkcycloadditionequipment acquisitionexperiencehigh resolution imagingimaging facilitiesimaging modalityinstrumentlight microscopylipid transportmass spectrometermicroscopic imagingmutantnanomachinenovelnovel strategiesoperationprotein expressionprotein purificationrecruitsample collectionsample fixationtooltrafficking
项目摘要
Core A: Imaging, Protein Production, and Chemical Biology Core
SUMMARY/ABSTRACT
The goal of the Imaging, Protein Production, and Chemical Biology Core is to maximize the scientific progress
and productivity of PPG investigators by providing essential services and reagents. The core will perform three
major functions for the PPG: (1) advanced light and electron microscopy imaging;; (2) protein and antibody
production;; and (3) chemical proteomics. All three PPG component projects will utilize at least two core services,
and two of the projects will utilize all three. Centralizing these activities within a core will benefit the PPG by
increasing productivity and reducing costs. The core will provide full-service scanning and transmission electron
microscopy, standard and live-cell confocal fluorescence microscopy, and NanoSIMS imaging. The latter is a
mass spectrometry–based imaging modality that makes it possible to create high-resolution images of cells and
tissues based solely on their isotopic content. PPG investigators will use NanoSIMS to visualize and quantify the
localization and movement of lipids in cells and tissues. PPG investigators will also study new molecules and
novel mechanisms regulating lipid transport and signaling, for which few reagents exist. To assist these
investigations, the core will produce protein and antibody reagents for PPG studies (e.g., soluble GPIHBP1,
stable isotope–labeled ALO-D4, 5D2 Fab fragments). Finally, the core will perform Activity-Based Chemical
Proteomics and isotopic Tandem Orthogonal Proteolysis‒Activity-Based Protein Profiling. These state-of-the-art
proteomics discovery platforms will be used to identify proteins involved in the intracellular trafficking of HDL-
derived cholesterol and the regulation of STING signaling by cholesterol. For the next five years, the core is
poised—with the experience, robust protocols, and experienced personnel—to provide vital services to PPG
investigators.
核心A:成像,蛋白质生产和化学生物学核心
总结/摘要
成像,蛋白质生产和化学生物学核心的目标是最大限度地提高科学进步
通过提供基本服务和试剂,提高PPG调查人员的生产力。核心将执行三项任务
PPG的主要功能:(1)先进的光学和电子显微镜成像;(2)蛋白质和抗体
PPG的所有三个组成项目将利用至少两个核心服务,
将这些活动集中在一个核心内将有利于项目编制补助金,
提高生产率,降低成本。核心将提供全方位服务的扫描和透射电子
显微镜,标准和活细胞共聚焦荧光显微镜,和NanoSIMS成像。后者是一个
- 基于质谱的成像模式,其使得可以创建细胞的高分辨率图像,
PPG研究人员将使用NanoSIMS来可视化和量化组织中的同位素含量。
细胞和组织中脂质的定位和运动。PPG研究人员还将研究新的分子,
调节脂质转运和信号传导的新机制,其试剂很少。
研究,核心将生产用于PPG研究的蛋白质和抗体试剂(例如, 可溶性GPIHBP 1,
最后,核心将进行基于活性的化学分析,
蛋白质组学和同位素串联正交蛋白质水解酶活性分析的基础上的蛋白质谱。这些国家的最先进的
蛋白质组学发现平台将用于鉴定参与细胞内高密度脂蛋白转运的蛋白质
衍生胆固醇和胆固醇调节STING信号。在未来五年,核心是
具备丰富的经验、强大的协议和经验丰富的人员,为PPG提供重要服务
investigators.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Loren Gi Fong其他文献
Loren Gi Fong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Loren Gi Fong', 18)}}的其他基金
Imaging, Protein Production, and Chemical Biology Core
成像、蛋白质生产和化学生物学核心
- 批准号:
10161850 - 财政年份:2019
- 资助金额:
$ 51.48万 - 项目类别:
Imaging, Protein Production, and Chemical Biology Core
成像、蛋白质生产和化学生物学核心
- 批准号:
10397412 - 财政年份:2019
- 资助金额:
$ 51.48万 - 项目类别:
Development of a New Therapeutic Approach for Prelamin A Diseases
Prelamin A 疾病新治疗方法的开发
- 批准号:
9459813 - 财政年份:2014
- 资助金额:
$ 51.48万 - 项目类别:
Development of a New Therapeutic Approach for Prelamin A Diseases
Prelamin A 疾病新治疗方法的开发
- 批准号:
9027789 - 财政年份:2014
- 资助金额:
$ 51.48万 - 项目类别:
New Therapeutic Approaches for Hutchinson-Gilford Progeria Syndrome
哈钦森-吉尔福德早衰综合症的新治疗方法
- 批准号:
7839423 - 财政年份:2009
- 资助金额:
$ 51.48万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 51.48万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 51.48万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 51.48万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 51.48万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 51.48万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 51.48万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 51.48万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 51.48万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 51.48万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 51.48万 - 项目类别: